Inhibition of adenovirus multiplication by metabolic inhibitors.
D000256:Adenoviridae / Q000254:growth & development* / Q000276:immunology / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000956:Antigens, Viral; D000963:Antimetabolites / Q000494:pharmacology*; D002460:Cell Line; D003168:Complement Fixation Tests; D003510:Cyclohexanes / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D003588:Cytopathogenic Effect, Viral / Q000187:drug effects; D004279:DNA, Viral / Q000096:biosynthesis; D003609:Dactinomycin / Q000494:pharmacology; D003841:Deoxycytidine / Q000494:pharmacology; D006367:HeLa Cells; D006386:Hemagglutination Tests; D006801:Humans; D007668:Kidney / Q000196:embryology; D008937:Mitomycins / Q000494:pharmacology; D010881:Piperidones / Q000494:pharmacology; D013936:Thymidine / Q000494:pharmacology; D013997:Time Factors; D014764:Viral Proteins / Q000096:biosynthesis; D014779:Virus Replication / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D000956:Antigens, Viral; D000963:Antimetabolites; D003510:Cyclohexanes; D004279:DNA, Viral; D008937:Mitomycins; D010881:Piperidones; D014764:Viral Proteins; D003841:Deoxycytidine; D003609:Dactinomycin; D003513:Cycloheximide; D013936:Thymidine